NCT07499557

Brief Summary

Radiology and BAL in Vaping associated lung disease

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 25, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 11, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 24, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 30, 2026

Completed
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

12 months

First QC Date

March 24, 2026

Last Update Submit

March 24, 2026

Conditions

Vaping Related Disorder

Keywords

bronchoalveolar lavageVapingUltrasound

Outcome Measures

Primary Outcomes (1)

  • Diagnostic yield of radiology plus bronchoscopy in vaping associated lung diseases

    icu admission rate ,length of hospital stay ,mortality rate

    one year

Secondary Outcomes (1)

  • mortality

    one year

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

persons who had history of vaping alot of years with chest symptoms

You may qualify if:

  • \. Age ≥ 18 years
  • \. Acute respiratory symptoms (dyspnea, cough, chest discomfort, or hypoxemia.
  • \. Documented use of E-cigarettes or vaping products within 90 days.
  • \. Availability of CT chest imaging and chest ultrasound at presentation.
  • \. BAL performed during the initial diagnostic work-up.

You may not qualify if:

  • \- 1-Confirmed alternative diagnoses such as cardiac failure, infectious pneumonia, pulmonary embolism, autoimmune disease, or drug-induced lung injury.
  • Refusal of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria main university hospital

Alexandria, Sidi Bishr, 5060, Egypt

Location

Related Links

MeSH Terms

Conditions

Vaping

Condition Hierarchy (Ancestors)

SmokingBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
mohamed sabry hassan

Study Record Dates

First Submitted

March 24, 2026

First Posted

March 30, 2026

Study Start

January 25, 2025

Primary Completion

January 11, 2026

Study Completion

March 25, 2026

Last Updated

March 30, 2026

Record last verified: 2026-03

Locations

EG(1)